🦊/Companies

Advaxis

Monmouth Junction, US · Delaware corporation · 1 known investors

Find your way into Advaxis

106 people in our graph share verified history with the Advaxis team — schools, employers, funds. One of them is your warm intro.

Claude Ritterunlockedknows Igor Gitelman · together at UBS Painewebber (overlapped)
×4knows the team · via UBS Painewebber
×7knows the team · via Pace University - Lubin School of Business

Founders & leadership

IGIgor Gitelman
Igor GitelmaninExecutiveIgor Gitelman has held financial leadership roles including Interim Chief Financial Officer at Ayala Pharmaceuticals and Chief Financial Officer at Accu Reference Medical Lab. He holds a CPA license, an MBA degree, and SAP Certified Application Associate credential, with over 20 years of experience in accounting, finance, and audit.
AG
Andres GutierrezExecutive
KB
Kenneth BerlinExecutive
TM
Thomas MooreinExecutive
JR
John RothmanExecutive
MJ
Mark J. RosenblumExecutive
RA
Roni AppelNamed on SEC filing

Board

DSDavid Sidransky
David SidranskyinBoard directorCo-Founder and Managing Partner at Israel Biotech Fund
SK
Samir KhleifBoard director
RB
Richard BermanBoard director
JP
James PattonBoard director
TM
Thomas McKearnBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$17.3M disclosed across 4 rounds · 2012–2023

$433.8KraisedNov 2023 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Andres GutierrezExecutive Officer
  • Igor GitelmanExecutive Officer
  • Pini OrbachDirector
  • Murray GoldbergDirector
  • Vered Bisker-LeibDirector
  • Yuval CabillyDirector
  • Bridget MartellDirector
  • Roy GolanExecutive Officer
  • Robert SpiegelDirector
  • David SidranskyDirector
  • Roni AppelDirector
  • Ken A. BerlinDirector, Executive Officer
Offering amount
$433.8K
Amount sold
$433.8K
First sale
Oct 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$4.8MraisedFeb 2022 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kenneth BerlinExecutive Officer, Director
  • Samir KhleifDirector
  • Igor GitelmanExecutive Officer
  • Roni AppelDirector
  • James PattonDirector
  • Andres GutierrezExecutive Officer
  • David SidranskyDirector
  • Richard BermanDirector
Offering amount
$4.8M
Amount sold
$4.8M
Minimum investment
$380K
Finders' fees
$295K
Placement agents
A.G.P./Alliance Global Partners
First sale
Jan 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$11.1MraisedApr 2021 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Samir KhleifDirector
  • Richard BermanDirector
  • Igor GitelmanDirector
  • Andres GutierrezExecutive Officer
  • Roni AppelDirector
  • Kenneth BerlinExecutive Officer, Director
  • David SidranskyDirector
  • James PattonDirector
Offering amount
$11.1M
Amount sold
$11.1M
Minimum investment
$3M
Finders' fees
$1.1M
Placement agents
A.G.P./Alliance Global Partners
First sale
Apr 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1MraisedFeb 2012 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas MooreExecutive Officer, Director
  • Richard BermanDirector
  • John RothmanExecutive Officer
  • Thomas McKearnDirector
  • Roni A. AppelDirector
  • James PattonDirector
  • Mark J. RosenblumExecutive Officer
Amount sold
$1M
Sales commissions
$73.3K
Placement agents
Rodman & Renshaw, LLC
First sale
Jan 2012
Incorporated
Corporation, Delaware
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Frequently asked questions

Who are Advaxis's investors?
Advaxis's investors include Israel Biotech Fund.
How much funding has Advaxis raised?
Advaxis has disclosed $17.3M raised across 4 rounds.
Where is Advaxis headquartered?
Advaxis is headquartered in Monmouth Junction, US.